Kövess minket:

Infúziós terápia – letisztultan, átláthatóan

Vizsgálat és labor
Átlátható árlista
Felügyelt kezelés

Rövid tájékoztatás: az infúziós terápia nem helyettesíti az alapbetegségek kivizsgálását/kezelését. Egyes hatóanyagok esetén a klinikai bizonyítékok korlátozottak; ezért transzparensen megjelöljük a fő forrásokat a lap alján.

Még sosem voltam infúziós terápián! Mi a teendő?

Válassz kezeléseink közül:

Hidratálás · electrolit pótlás

Electrolit complex

Részletek

25 000 Ft

Energizálás · detox

Myers cocktail

Részletek

60 000 Ft

B12

Részletek

20 000 Ft

NAD+ 200 mg

Részletek

90 000 Ft

Glutation 600 mg

Részletek

25 000 Ft

Curcumin 50 mg

Részletek

45 000 Ft

Rezveratrol 25 mg

Részletek

50 000 Ft

Curcumin 100 mg + Rezveratrol 50 mg

Részletek

95 000 Ft

Irodalomjegyzék:

  1. Hanai, H. et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin. Gastroenterol. Hepatol. 4, 1502–1506 (2006). https://doi.org/10.1016/j.cgh.2006.08.008
  2. Wai, H. S. et al. Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis. BMC Complement. Med. Ther. 25, 292 (2025). https://doi.org/10.1186/s12906-025-05045-z
  3. Saghatelyan, T. et al. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: a comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine 70, 153218 (2020). https://doi.org/10.1016/j.phymed.2020.153218
  4. Delpino, F. M. et al. Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 62, 4465–4480 (2022). https://doi.org/10.1080/10408398.2021.1875980
  5. Nyambuya, T. M. et al. A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Glycaemic Control in Type 2 Diabetes. Molecules 25, 5645 (2020). https://doi.org/10.3390/molecules25235645
  6. Hanai, H. et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin. Gastroenterol. Hepatol. 4, 1502–1506 (2006). https://doi.org/10.1016/j.cgh.2006.08.008
  7. Wai, H. S. et al. Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis. BMC Complement. Med. Ther. 25, 292 (2025). https://doi.org/10.1186/s12906-025-05045-z
  8. Saghatelyan, T. et al. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: a comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine 70, 153218 (2020). https://doi.org/10.1016/j.phymed.2020.153218
  9. Delpino, F. M. et al. Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 62, 4465–4480 (2022). https://doi.org/10.1080/10408398.2021.1875980
  10. Nyambuya, T. M. et al. A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Glycaemic Control in Type 2 Diabetes. Molecules 25, 5645 (2020). https://doi.org/10.3390/molecules25235645
  11. Self, W. H. et al. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N. Engl. J. Med. 378, 819–828 (2018). https://doi.org/10.1056/NEJMoa1711586
  12. Semler, M. W. et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N. Engl. J. Med. 378, 829–839 (2018). https://doi.org/10.1056/NEJMoa1711584
  13. Ali, A. et al. Intravenous micronutrient therapy (Myers’ Cocktail) for fibromyalgia: a placebo-controlled pilot study. J. Altern. Complement. Med. 15, 247–257 (2009). https://doi.org/10.1089/acm.2008.0410
  14. Gaby, A. R. Intravenous nutrient therapy: the “Myers’ cocktail”. Altern. Med. Rev. 7, 389–403 (2002).
  15. Wang, H. et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst. Rev. 3, CD004655 (2018). https://doi.org/10.1002/14651858.CD004655.pub3
  16. Wolffenbuttel, B. H. R. et al. Vitamin B12. BMJ 383, e071725 (2023). https://doi.org/10.1136/bmj-2022-071725
  17. Cascinu, S. et al. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 13, 26–32 (1995). https://doi.org/10.1200/JCO.1995.13.1.26
  18. Smyth, J. F. et al. Glutathione reduces the toxicity and improves quality of life of women treated with cisplatin and cyclophosphamide for ovarian cancer. Ann. Oncol. 8, 569–573 (1997). https://doi.org/10.1023/A:1008211226339
  19. Cascinu, S. et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 20, 3478–3483 (2002). https://doi.org/10.1200/JCO.2002.07.061
    TERMÉK: NAD+200mg
  20. Grant, R. et al. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Front. Aging Neurosci. 11, 257 (2019). https://doi.org/10.3389/fnagi.2019.00257
  21. Mortensen, S. A. et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2, 641–649 (2014). https://doi.org/10.1016/j.jchf.2014.06.008
  22. Xu, J. et al. Efficacy and safety of coenzyme Q10 in heart failure: a meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord. 24, 592 (2024). https://doi.org/10.1186/s12872-024-04232-z